glp-1 agonists muscle loss Do drugs shrink your muscles? New study explains the risks and what to do GLP‐1 receptor agonists and muscle

Merkel M et al

Common praise points include the gentleness of the treatment, the convenience of incorporating it into existing routines, and the noticeable improvement in skin texture and tone

(6 February 2014)

[15] Other environmental and occupation exposures such as exposure to metal dust, wood dust, coal dust, silica, stone dust, biologic dusts coming from hay dust or mold spores or other agricultural products, and occupations related to farming/livestock have also been shown to increase the risk for IPF

guidance from healthcare professionals improves safety and ensures injections target appropriate muscle or subcutaneous tissue

Here is what the evidence actually shows